P697-0695 Screening compound: 2-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidino}-N~1~-phenylacetamide

P697-0695 Screening compound: 2-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidino}-N~1~-phenylacetamide
P697-0695 Screening compound: 2-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidino}-N~1~-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P697-0695
2-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidino}-N~1~-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P697-0695

Molecular Formula

C21H21FN4O2 (C21 H21 FN4 O2)

Compound Name

2-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]piperidino}-N~1~-phenylacetamide

IUPAC name

2-{2-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]piperidin-1-yl}-N-phenylacetamide

SMILES

O=C(CN(CCCC1)C1c1nc(-c(cc2)ccc2F)no1)Nc1ccccc1

InChI

InChI=1S/C21H21FN4O2/c22-16-11-9-15(10-12-16)20-24-21(28-25-20)18-8-4-5-13-26(18)14-19(27)23-17-6-2-1-3-7-17/h1-3,6-7,9-12,18H,4-5,8,13-14H2,(H,23,27)/t18-/m0/s1

InChI Key

FLPCSGZANZKODR-SFHVURJKSA-N

MDL Number (MFCD)

MFCD27612238

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

380.42

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.402

Distribution Coefficient, logD

4.402

Water Solubility, LogSw

-4.30

Polar Surface Area

58.386

Acid Dissociation Constant (pKa)

12.58

Base Dissociation Constant (pKb)

2.37

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.57

P697-0695 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P697-0695 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P697-0695?
Check Price and Availability of P697-0695, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P697-0695 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P697-0695
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P697-0695
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P697-0695 available by request